Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Annals of Surgical Oncology

Volumn 14, Issue 12, 2007, Pages 3443-3452

  Kusamura, Shigeki ^a   Baratti, Dario ^a   Antonucci, Adelmo ^a   Younan, Rami ^b   Laterza, Barbara ^a   Oliva, Grazia Daniela ^a   Gavazzi, Cecilia ^a   Deraco, Marcello ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Hyperthermic intraperitoneal chemotherapy; Peritonectomy; Toxicity

Indexed keywords

AMYLASE; CISPLATIN; DOXORUBICIN; MITOMYCIN C;

ABDOMINAL SURGERY; ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CARCINOMATOSIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE CLASSIFICATION; DRUG DOSE COMPARISON; ENZYME DEFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERAMYLASEMIA; HYPERTHERMIC THERAPY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PANCREAS FISTULA; PANCREATITIS; PERITONEAL SURFACE MALIGNANCY; PERITONECTOMY; PERITONEUM CANCER; PERITONEUM MESOTHELIOMA; PERITONEUM PSEUDOMYXOMA; PERITONEUM SURGERY; POSTOPERATIVE COMPLICATION; RISK FACTOR; SPLENECTOMY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; HYPERAMYLASEMIA; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; MITOMYCIN; MORBIDITY; NEOPLASM RECURRENCE, LOCAL; PANCREATIC FISTULA; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 36348936092     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9551-0     Document Type: Article

References (34)

1. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004; 11(4):393-8
2. Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol 2003; 83:147-53
3. Ryu KS, Kim JH, Ko HS, Kim JW, Ahn WS, Park YG, Kim SJ, Lee JM. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol 2004; 94:325-32
4. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-Portilla A, Shen P, Deraco M, Rat P. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004; 22:3284-92
5. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21:3737-43
6. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghausen SE, Dalton RR, Steves MA, Sugarbaker PH. Analysis of morbidity and mortality in 60 patients with peritoneal. carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996; 77:2622-9
7. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6:790-6
8. Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, Trillet-Lenoir V, Sayag-Beaujard AC, Francois Y, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003; 10:863-9
9. Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FA. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85:61-7
10. Shen P, Hawksworth J, Lovato J, Loggie BW, Geisinger KR, Fleming RA, Levine EA. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004; 11:178-86
11. Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006; 106(5):1144-53
12. Tansung T, Sugarbaker PH. Management of pancreatitis due to pancreatic injury in cytoreductive surgery. Reg Cancer Treat 1995; 8:180-4
13. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29-42
14. Sugarbaker PH. Laser-mode electrosurgery. Cancer Treat Res 1996; 82:375-85
15. Younan R, Kusamura S, Baratti D, Oliva GD, Costanzo P, Favaro M, Gavazzi C, Deraco M. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2005; 12(11):910-8
16. Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 1996; 15:49-58
17. Fujimoto S, Takahashi M, Kobayashi K, Kure M, Masaoka H, Ohkubo H, Isaka S, Shimazaki J. Combined treatment of pelvic exenterative surgery and intra-operative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: report of a case. Surg Today 1993; 23:1094-8
18. Rossi CR, Foletto M, Mocellin S, Pilati P, De SM, Deraco M, Cavaliere F, Palatini P, Guasti F, Scalerta R, Lise M. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study. Cancer 2002; 94:492-9
19. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M. International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138(1):8-13
20. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA 2004; 291(23):2865-8
21. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics, Second Edition. Norwalk, Connecticut. Appleton & Lange
22. http://www.peritonealworkshop2006.com, last access April 2007
23. Chand B, Walsh RM, Ponsky J, Brody F. Pancreatic complications following laparoscopic splenectomy. Surg Endosc 2001; 15(11):1273-6
24. Delaitre B, Champault G, Barrat C, Gossot D, Bresler L, Meyer C, Collet D, Samama G. Laparoscopic splenectomy for hematologic diseases. Study of 275 cases. French Society of Laparoscopic Surgery. Ann Chir 2000; 125(6):522-9. French
25. Hendricks T, Martens MF, Huyben CM, Wobbes T. Inhibition of basal and TGF beta-induced fibroblast collagen synthesis by antineoplastic agents. Implications for wound healing. Br J Cancer 1993; 67(3):545-50
26. Rattner DW, Gu ZY, Vlahakes GJ, Warshaw AL. Hyperamylasemia after cardiac surgery. Incidence, significance, and management. Ann Surg 1989; 209(3):279-83
27. Hashimoto N, Haji S, Nomura H, Ohyanagi H. Hyperamylasemia after hepatic resection. Hepatogastroenterology 2003; 50(53):1472-3
28. Baniel J, Leibovitch I, Foster RS, Rowland RG, Bihrle R, Donohue JP. Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 1995; 154(4):1373-5
29. Korenaga D, Watanabe A, Baba H, Saito A, Maehara Y, Sugimachi K. Hyperamylasemia associated with lymphadenectomy in patients surgically treated for gastric cancer. Eur J Surg Oncol 1992; 18(2):135-41
30. Leclerc P, Forest JC. Variations in amylase isoenzymes and lipase during acute pancreatitis, and in other disorders causing hyperamylasemia. Clin Chem 1983; 29(6):1020-3
31. Baronofsky ID, Wwalton W, Noble JF. Occult injury to the pancreas following splenectomy. Surgery 1951; 29(6):852-7
32. Paajanen H, Nuutinen P, Harmoinen A, Poyhonen M, Pitkanen O, Nordback I, Gronroos J, Nevalainen TJ. Hyperamylasemia after cardiopulmonary bypass: pancreatic cellular injury or impaired renal excretion of amylase? Surgery 1998; 123(5):504-10
33. Li-Ling J, Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg 2001; 88(2):190-9
34. Balcom JH 4th, Keck T, Warshaw AL, Graeme-Cook F, Fernandez-del Castillo C. Prevention of pancreatic fistula with a new synthetic, absorbable sealant: evaluation in a dog model. J Am Coll Surg 2002; 195(4):490-6